Search

Your search keyword '"Janss AJ"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Janss AJ" Remove constraint Author: "Janss AJ"
46 results on '"Janss AJ"'

Search Results

2. A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma.

3. Vision-related quality-of-life in pediatric primary brain tumor patients.

4. Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.

5. Guidelines for Treatment and Monitoring of Adult Survivors of Pediatric Brain Tumors.

6. Headache, elevated tumor markers, and pituitary mass.

7. Diffuse leptomeningeal neuroepithelial tumor: 9 pediatric cases with chromosome 1p/19q deletion status and IDH1 (R132H) immunohistochemistry.

8. Transient enlargement of craniopharyngioma after radiation therapy: pattern of magnetic resonance imaging response following radiation.

9. A phase II study of metronomic oral topotecan for recurrent childhood brain tumors.

10. Seventeen-year-old adolescent with pituitary abscess.

11. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma.

12. De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system.

13. Childhood intracranial ependymoma: twenty-year experience from a single institution.

14. Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapy.

15. Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era.

16. Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults.

17. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma.

18. Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.

19. Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas.

20. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.

21. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.

22. High microvessel density in primitive neuroectodermal brain tumors of childhood.

23. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.

24. Reversible posterior leukoencephalopathy during the treatment of acute lymphoblastic leukemia.

25. Prognostic significance of Ki-67 (MIB-1) proliferation index in childhood primitive neuroectodermal tumors of the central nervous system.

26. Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control.

27. Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin.

28. Abundance of apoptotic neoplastic cells in diagnostic biopsy samples is not a prognostic factor in childhood primitive neuroectodermal tumors of the central nervous system.

29. Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.

30. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.

31. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.

32. Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy.

33. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors.

34. Quality of life of adult survivors of germinomas treated with craniospinal irradiation.

35. Neuro-oncology-endocrinology interface: A patient who earned her salt.

36. Caffeine and staurosporine enhance the cytotoxicity of cisplatin and camptothecin in human brain tumor cell lines.

37. Synergistic cytotoxicity of topoisomerase I inhibitors with alkylating agents and etoposide in human brain tumor cell lines.

38. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.

39. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.

40. Isochromosome 17q demonstrated by interphase fluorescence in situ hybridization in primitive neuroectodermal tumors of the central nervous system.

41. Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up.

42. Superficial siderosis of the central nervous system: magnetic resonance imaging and pathological correlation. Case report.

43. Effect of spinal norepinephrine depletion on descending inhibition of the tail flick reflex from the locus coeruleus and lateral reticular nucleus in the rat.

44. Dissociation of antinociceptive from cardiovascular effects of stimulation in the lateral reticular nucleus in the rat.

45. Brainstem and spinal pathways mediating descending inhibition from the medullary lateral reticular nucleus in the rat.

46. Quantitative characterization and spinal pathway mediating inhibition of spinal nociceptive transmission from the lateral reticular nucleus in the rat.

Catalog

Books, media, physical & digital resources